Osaic Holdings
CYTK icon

Osaic Holdings’s Cytokinetics CYTK Stock Holding History

Osaic Holdings’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$275 – 7920
2025
Q3 		$275 Hold
1
– – ﹤0.01% 7653
2025
Q2 		$250 Hold
1
– – ﹤0.01% 7472
2025
Q1 		$766 Hold
1
– – ﹤0.01% 6893
2024
Q4 		$1.21K Hold
1
– – ﹤0.01% 6774
2024
Q3 		$1.54K Hold
1
– – ﹤0.01% 6707
2024
Q2 		$1.5K Buy
+1
New +$60 ﹤0.01% 6702

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's CYTK Position: Q1 2026 in Review

Osaic Holdings reduced its Cytokinetics (CYTK) stake by 3% in Q1 2026, selling an estimated $99.4K and leaving 50,872 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Osaic Holdings first reported a position in CYTK in Q1 2020 and has held it in 25 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Osaic Holdings held 50,872 shares of Cytokinetics worth $3.35M as of Q1 2026.
  • Osaic Holdings sold 1,564 Cytokinetics shares in Q1 2026, an estimated $99.4K.
  • Cytokinetics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1647 holding.
  • Osaic Holdings first reported a position in Cytokinetics in Q1 2020 and has held it in 25 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.